Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
rrp5RFqZ22EfnXRD